businesspress24.com - Daxor Corporation Announces Payment of a Dividend
 

Daxor Corporation Announces Payment of a Dividend

ID: 1175654

(firmenpresse) - NEW YORK, NY -- (Marketwire) -- 11/29/12 -- Daxor Corporation (NYSE MKT: DXR), an investment company with medical instrumentation and biotechnology operations, announced the payment of a dividend today.

The Board of Directors has approved payment of a dividend of $0.10 per share. The dividend will be paid on Thursday, December 27th to shareholders of record on Tuesday, December 11th. The Company previously paid a dividend in 2012 of $0.10 per share on August 24th.

In 2011, the Company paid a total dividend of $0.25 per share as follows: $0.15 per share on June 16th and $0.10 per share on November 30th.

Daxor Corporation manufactures and markets the BVA-100 Blood Volume Analyzer which is used in conjunction with Volumex, Daxor's single use diagnostic kit. The BVA-100 provides key information that can be used to diagnose and treat various medical conditions including congestive heart failure, hypertension, anemia, blood loss during surgery, trauma, and shock (collapse of blood pressure).

At the present time, physicians must treat these conditions by guessing whether or not they are due to volume expansions or contractions. The Blood Volume Analyzer allows precise quantitation of patients' total blood volume and red blood cell volume, which takes the guesswork out of this process. Appropriate therapies can then be employed to correct excesses or deficits in volume, leading to better outcomes for patients.

For more information regarding Daxor Corporation's Blood Volume Analyzer BVA-100, visit Daxor's website at .



Daxor Contact Information:
David Frankel
Chief Financial Officer
212-330-8504


Richard Dunn
Director of Operations
212-330-8502


Diane Meegan
Investor Relations
212-330-8512




Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Cytomedix Announces CE Mark Approval for Angel(R) cPRP System for Processing Blood and Bone Marrow Aspirate
GeoVax Labs to Present at Fifth Annual LD Micro Conference
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 29.11.2012 - 07:30 Uhr
Sprache: Deutsch
News-ID 1175654
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

NEW YORK, NY


Phone:

Kategorie:

Hospitals, Facilities and Providers


Anmerkungen:


Diese Pressemitteilung wurde bisher 118 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Daxor Corporation Announces Payment of a Dividend
"
steht unter der journalistisch-redaktionellen Verantwortung von

Daxor Corp. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Daxor Corp.



 

Who is online

All members: 10 565
Register today: 0
Register yesterday: 0
Members online: 1
Guests online: 79


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.